ARF1 and cancer: Although ARF1 has several favorable characteristics, i.e. crystal structure and inhibitors in Plasmodium and cancer cells, computational prediction and experimental validation are needed to identify effective and potent Plasmodium inhibitors since a general druggability challenge with small GTPases is the displacement of GTP binding.